| Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer | Annals of Oncology | 2018 | 302 |
| Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer | Seminars in Cancer Biology | 2018 | 181 |
| Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases | Acta Oncológica | 2018 | 157 |
| Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study | Journal of Allergy and Clinical Immunology | 2018 | 127 |
| Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis | JAMA Psychiatry | 2018 | 114 |
| Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer | Nature Communications | 2018 | 103 |
| Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study | Lancet Respiratory Medicine,the | 2018 | 99 |
| Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study | Journal of Hepatology | 2018 | 86 |
| Systemic treatments for metastatic cutaneous melanoma | The Cochrane Library | 2018 | 85 |
| An early European experience with transapical off-pump mitral valve repair with NeoChord implantation | European Journal of Cardio-thoracic Surgery | 2018 | 83 |
| Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells | PLoS Pathogens | 2018 | 78 |
| Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡ | Annals of Oncology | 2018 | 77 |
| Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade | Journal of Translational Medicine | 2018 | 73 |
| The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI) | European Journal of Surgical Oncology | 2018 | 71 |
| Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial | Pharmacological Research | 2018 | 66 |
| Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment | Journal of the American Society of Nephrology: JASN | 2018 | 66 |
| Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? | World Journal of Gastroenterology | 2018 | 66 |
| Etiopathogenesis of autoimmune hepatitis | Journal of Autoimmunity | 2018 | 62 |
| Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI) | European Heart Journal | 2018 | 61 |
| The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention | BioMed Research International | 2018 | 61 |
| Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score | The Lancet Gastroenterology and Hepatology | 2018 | 60 |
| Proton pump inhibitors: use and misuse in the clinical setting | Expert Review of Clinical Pharmacology | 2018 | 60 |
| Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis | Transplant International | 2018 | 57 |
| nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial | Annals of Oncology | 2018 | 52 |
| Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time | Annals of Oncology | 2018 | 51 |
